Likewise, reduced expression of pro-apoptotic Bax levels has been associated with poor response to chemotherapy and shorter overall survival for patients with breast cancers, whereas enhanced expression of Bax protein correlate with a good response to chemotherapy in vivo [29]. The gene discussed is BAX; the disease is breast carcinoma.